Monitoring respiratory depression in patients receiving opioids is important because it is a dose-related side effect that can lead to serious complications.

• A. It is a dose-related side effect that can lead to serious complications.
• B. It indicates improved analgesia.
• C. It is unrelated to dose.
• D. It only occurs in adults.

Answer: (A)

Opioid-induced respiratory depression is a dose-related adverse effect that can progress to life-threatening hypoventilation. Because the risk rises with higher doses and with other CNS depressants, careful dosing and vigilant monitoring are essential in every patient, especially children. Watch for slower or shallower breathing, reduced level of consciousness, and drops in oxygen saturation; these signs can appear quickly in pediatrics, making early detection crucial. Monitoring allows timely dose adjustments or interventions, such as providing supportive care or reversing effects if necessary. This statement is the best because it directly links the risk to the dose and underscores why ongoing monitoring is necessary to prevent serious complications. It’s not about improved analgesia, it’s not unrelated to dose, and it can occur in both adults and children.